Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial

By Brinkhaus Benno   Hentschel Christian   Keudell Christoph Von   Schindler Gernot   Lindner Martin   Stützer Hartmut   Kohnen Ralf   Willich Stefan   Lehmacher Walter   Hahn Eckhart G.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 936-943

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation

By Out HJ  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 622-627

Oxford University Press

Access to resources Recommend Favorite

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

By Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 10, 2008-01 ,pp. : 1202-1211

Informa Healthcare

Access to resources Recommend Favorite

Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam

By Maehata Yuji  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 387-393

Springer Publishing Company

Access to resources Recommend Favorite